Futura Gains EU CE Mark For Drug-Free OTC Erectile Dysfunction Treatment
Executive Summary
Futura Medical has received a CE Mark for its MED3000 erectile dysfunction treatment, which combines in gel form a mixture of volatile and non-volatile ingredients.
You may also be interested in...
Futura Strikes Deal With Menarini To Commercialize MED3000 ED Gel In South Korea
South Korean erectile dysfunction sufferers may soon be able to acess Futura Medical's drug-free MED3000 treatment thanks to a deal with Menarini Korea Limited, a wholly owned subsidiary of Italy’s Menarini Group, for exclusive commercialization rights in the country.
Futura Takes Drug-Free Erectile Dysfunction Gel To Latin America
UK based Futura Medical has struck a deal with m8 Pharmaceuticals to take its drug-free erectile dysfunction gel to Brazil and Mexico.
Futura’s Drug-Free Erectile Dysfunction Gel On Track For US And EU Launch
Futura Medical's latest meeting with the FDA puts the UK start-up one step closer to launching its drug-free erectile dysfunction gel MED3000 in the US in 2023, while the firm gets ready to launch in the EU next year following its recent CE-mark approval.